MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.

Source:http://linkedlifedata.com/resource/pubmed/id/19584161

Clin. Cancer Res. 2009 Jul 15 15 14 4622-9

Download in:

View as

Triples

General Info

PMID
19584161